Start-up Contest

As the Managing Director for Healthcare at Google, Ryan Olohan leads the teams responsible for developing and managing Google’s relationships with pharmaceutical and consumer health companies. Ryan and his teams partner with the largest companies in the world to leverage Google’s consumer platforms while connecting the vast health resources and innovation at Google in an effort to push the industry forward. His relentless push is why he was selected by MM&M as a “Top 40 Healthcare Transformer of 2016”, PRWeek’s Top 50 Healthcare Influencer for 2017 and 2018, and the 2017 Irish America Top Business 100.

Before Healthcare, Ryan spent the first half of his 12 years at Google overseeing the CPG industry as the Head of Consumer Packaged Goods. Prior to Google, Ryan was a consultant for Hewitt Associates and a Vice President at Bank of NY Mellon before getting the itch to lead Business Development at two prominent startups. Outside of his day job, he is a frequent speaker at industry events and a board member of the Consumer Healthcare Products Association Foundation, the Digital Health Coalition, and an advisor for the Chopra Foundation,. He is also the founder of the Google Healthcare Advisory Board and the co-author of the widely acclaimed “Pharma 3D” (www.Pharma3D.com) in partnership with Google, McKinsey, and Wharton. When not at Google, Ryan “relaxes” at home in New Jersey with his wife and seven children.

Eyal is EY Israel’s Life Sciences Sector Leader based in Tel Aviv, Israel. He has over 20 years of national and global experience serving Growth and Life Sciences clients. Eyal holds a BA in Accounting from Tel Aviv Management College. He is a Certified Public accountant in Israel. Eyal has been serving as Teva Pharmaceuticals Global Client Service Partner for the last 8 years, leading EY global activities and relationships. Eyal has served clients in every stage of growth, and helped many companies from the early stage through the challenges of launching initial products and establishing a market leader position. Eyal has provided consulting to various Growth and Life Sciences companies on planning strategy, acquisitions, divestitures, due diligence, and post-merger integrations. He has worked on hundreds of public and private financings, including over 40 IPOs and follow-on offerings. Eyal’s professional experience includes corporate alliances, spinouts, joint ventures and mergers & acquisitions.

Udi Mokady is the Chairman and CEO of CyberArk, and a pioneer in establishing the Privileged Account Security software market. Since co-founding the company in 1999, Mokady has entrenched CyberArk as the market leader. During his tenure at CyberArk, Mokady has also served as CyberArk’s chief strategist and visionary, overseeing global expansion, management, execution and corporate development.

Since assuming the position of CEO in 2005, Mokady’s leadership and direction has been instrumental in guiding CyberArk to achieve record growth, while accelerating overall market adoption for privileged access security solutions to protect against an evolving advanced threat landscape. Mokady was elected Chairman of the Board in 2016.

Prior to his role as CEO, Mokady served as CyberArk’s COO between 1999 and 2005. During this time, Mokady established CyberArk’s US headquarters in Newton, Massachusetts and successfully transitioned the company to a market leadership position in Privileged Access Security by helping organizations to recognize the connection between privileged access and advanced internal and external security threats. Mokady also orchestrated the company’s market expansion in the US, Europe, and Asia by elevating awareness of privilege-related security and compliance risks while successfully implementing and managing channel development, international sales operations and marketing for CyberArk’s award winning information security products.

Prior to CyberArk, Mokady specialized in legal management and business development for international high-tech companies. He previously served as the general counsel at Tadiran Spectralink, a highly specialized producer of secure wireless communications systems.

Mokady received the 2018 Asper Award for Global Entrepreneurship from Brandeis University and a 2017 SC Media Reboot Award as a cyber security influencer. He was named the 2014 Ernst & Young Entrepreneur of the Year for the Technology Security category in New England. Mokady is a member of the Monetary Authority of Singapore (MAS) Cyber Security Advisory Panel and is a member of the Board of Directors of Demisto.

Marc Probst is the Chief Information Officer and Vice President at Intermountain Healthcare, an integrated delivery network (IDN) based in Salt Lake City, Utah. Marc is nationally recognized as a CIO and served on the Federal Healthcare Information Technology Policy Committee which assisted in developing HIT Policy for the U.S. Government. Marc has been involved with Information Technology and Healthcare services for over 30 years. Prior to Intermountain, Marc was a Partner with two large professional service organizations; Deloitte Consulting and Ernst & Young, serving healthcare provider and payer organizations. Marc has significant interest in the use of information technology to increase patient care quality and lower the costs of care. He is experienced in information technology planning, design, development, deployment and operation, as well as policy development for HIT related issues. Marc has served as a Board Member of several healthcare related organizations including the University of Utah School of Nursing, College of Health Information Management Executives (CHIME), and the Utah Food Bank. He is a frequent speaker on Health Information System strategy, innovation, analytics, standards and policy. Marc has a passion for the power of HIT for public and population health within the United States and for health improvement worldwide. Marc received a degree in Finance from the University of Utah and later a Masters of Business Management from George Washington University.

Christian Hein joined Novartis as Director, Digital Products in the newly created Group Digital Office, this year. He looks after several digital lighthouse projects in the transformation of Novartis towards Digital & Data, as well as strategic partnerships with major technology companies.

Before joining Novartis, Christian held several leadership positions at Amgen ranging from leading Strategic Planning to heading regional Business Development. In his most recent role, he was building up from scratch the Amgen Berlin Technology Hub, a Digital Innovation Lab. Within the hub, he hired and led a strong cross-functional innovation team with skills ranging from iOS development to digital service design, digital regulatory, technology scouting, and advanced analytics/data science.

He also lead the strategic investment of Amgen into the Israel-based eHealth Ventures, and was previously part of the core team of the corporate transformation initiative that lead to the creation of Amgen Digital Health. Before Amgen, Christian lead Global business intelligence and market research at Actelion Pharmaceuticals, and spend many years in consulting and as VC investor with life science companies ranging from small startups to major pharma and medtech companies.